Prucalopride Succinate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Prucalopride Succinate Product Information
Prucalopride Succinate is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Prucalopride. The product is supplied by Clearsynth under CAT No. CS-T-60876.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Prucalopride Succinate
CAS No.
179474-85-2
CAT No.
CS-T-60876
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C22H32ClN3O7
Molecular Weight
485.96
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Prucalopride Succinate is supplied with detailed characterization data compliant with regulatory guideline. Prucalopride Succinate can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Prucalopride.
Overview
"Prucalopride is a selective 5-HT4 receptor agonist used effective for chronic constipation, but is not currently approved in the U.S. Prucalopride is approved for the treatment of chronic constipation in Europe. "
Synonyms
Prucalopride Succinate
Application Notes
"Prucalopride is a selective 5-HT4 receptor agonist used effective for chronic constipation, but is not currently approved in the U.S. Prucalopride is approved for the treatment of chronic constipation in Europe. "
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.